IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-41986-0.html
   My bibliography  Save this article

A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models

Author

Listed:
  • Fabian Wirth

    (Neurimmune AG)

  • Fabrice D. Heitz

    (Neurimmune AG)

  • Christine Seeger

    (Neurimmune AG)

  • Ioana Combaluzier

    (Neurimmune AG)

  • Karin Breu

    (Neurimmune AG)

  • Heather C. Denroche

    (University of British Columbia)

  • Julien Thevenet

    (Univ-Lille, Inserm, CHU Lille)

  • Melania Osto

    (Vetsuisse Faculty of the University of Zürich)

  • Paolo Arosio

    (ETH Zürich)

  • Julie Kerr-Conte

    (Univ-Lille, Inserm, CHU Lille)

  • C. Bruce Verchere

    (University of British Columbia)

  • François Pattou

    (Univ-Lille, Inserm, CHU Lille)

  • Thomas A. Lutz

    (Vetsuisse Faculty of the University of Zürich)

  • Marc Y. Donath

    (University Hospital Basel)

  • Christoph Hock

    (Neurimmune AG
    University of Zürich)

  • Roger M. Nitsch

    (Neurimmune AG
    University of Zürich)

  • Jan Grimm

    (Neurimmune AG)

Abstract

In patients with type 2 diabetes, pancreatic beta cells progressively degenerate and gradually lose their ability to produce insulin and regulate blood glucose. Beta cell dysfunction and loss is associated with an accumulation of aggregated forms of islet amyloid polypeptide (IAPP) consisting of soluble prefibrillar IAPP oligomers as well as insoluble IAPP fibrils in pancreatic islets. Here, we describe a human monoclonal antibody selectively targeting IAPP oligomers and neutralizing IAPP aggregate toxicity by preventing membrane disruption and apoptosis in vitro. Antibody treatment in male rats and mice transgenic for human IAPP, and human islet-engrafted mouse models of type 2 diabetes triggers clearance of IAPP oligomers resulting in beta cell protection and improved glucose control. These results provide new evidence for the pathological role of IAPP oligomers and suggest that antibody-mediated removal of IAPP oligomers could be a pharmaceutical strategy to support beta cell function in type 2 diabetes.

Suggested Citation

  • Fabian Wirth & Fabrice D. Heitz & Christine Seeger & Ioana Combaluzier & Karin Breu & Heather C. Denroche & Julien Thevenet & Melania Osto & Paolo Arosio & Julie Kerr-Conte & C. Bruce Verchere & Franç, 2023. "A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-41986-0
    DOI: 10.1038/s41467-023-41986-0
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-41986-0
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-023-41986-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Jeff Sevigny & Ping Chiao & Thierry Bussière & Paul H. Weinreb & Leslie Williams & Marcel Maier & Robert Dunstan & Stephen Salloway & Tianle Chen & Yan Ling & John O’Gorman & Fang Qian & Mahin Arastu , 2016. "The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease," Nature, Nature, vol. 537(7618), pages 50-56, September.
    2. Yong Xu & Roberto Maya-Martinez & Nicolas Guthertz & George R. Heath & Iain W. Manfield & Alexander L. Breeze & Frank Sobott & Richard Foster & Sheena E. Radford, 2022. "Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    3. Aubin Michalon & Andreas Hagenbuch & Christian Huy & Evita Varela & Benoit Combaluzier & Thibaud Damy & Ole B. Suhr & Maria J. Saraiva & Christoph Hock & Roger M. Nitsch & Grimm, 2021. "A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells," Nature Communications, Nature, vol. 12(1), pages 1-12, December.
    4. Paolo Arosio & Thomas C. T. Michaels & Sara Linse & Cecilia Månsson & Cecilia Emanuelsson & Jenny Presto & Jan Johansson & Michele Vendruscolo & Christopher M. Dobson & Tuomas P. J. Knowles, 2016. "Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation," Nature Communications, Nature, vol. 7(1), pages 1-9, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jusung An & Kyeonghwan Kim & Ho Jae Lim & Hye Yun Kim & Jinwoo Shin & InWook Park & Illhwan Cho & Hyeong Yun Kim & Sunghoon Kim & Catriona McLean & Kyu Yeong Choi & YoungSoo Kim & Kun Ho Lee & Jong Se, 2024. "Early onset diagnosis in Alzheimer’s disease patients via amyloid-β oligomers-sensing probe in cerebrospinal fluid," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    2. Byung Jo Choi & Min Hee Park & Kang Ho Park & Wan Hui Han & Hee Ji Yoon & Hye Yoon Jung & Ju Yeon Hong & Md Riad Chowdhury & Kyung Yeol Kim & Jihoon Lee & Im-Sook Song & Minyeong Pang & Min-Koo Choi &, 2023. "Immunotherapy targeting plasma ASM is protective in a mouse model of Alzheimer’s disease," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    3. Matthias M. Schneider & Saurabh Gautam & Therese W. Herling & Ewa Andrzejewska & Georg Krainer & Alyssa M. Miller & Victoria A. Trinkaus & Quentin A. E. Peter & Francesco Simone Ruggeri & Michele Vend, 2021. "The Hsc70 disaggregation machinery removes monomer units directly from α-synuclein fibril ends," Nature Communications, Nature, vol. 12(1), pages 1-11, December.
    4. Rakesh Kumar & Tanguy Marchand & Laurène Adam & Raitis Bobrovs & Gefei Chen & Jēkabs Fridmanis & Nina Kronqvist & Henrik Biverstål & Kristaps Jaudzems & Jan Johansson & Guido Pintacuda & Axel Abelein, 2024. "Identification of potential aggregation hotspots on Aβ42 fibrils blocked by the anti-amyloid chaperone-like BRICHOS domain," Nature Communications, Nature, vol. 15(1), pages 1-10, December.
    5. Sheng Chen & Anuradhika Puri & Braxton Bell & Joseph Fritsche & Hector H. Palacios & Maurie Balch & Macy L. Sprunger & Matthew K. Howard & Jeremy J. Ryan & Jessica N. Haines & Gary J. Patti & Albert A, 2024. "HTRA1 disaggregates α-synuclein amyloid fibrils and converts them into non-toxic and seeding incompetent species," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    6. Shangran Qiu & Matthew I. Miller & Prajakta S. Joshi & Joyce C. Lee & Chonghua Xue & Yunruo Ni & Yuwei Wang & Ileana Anda-Duran & Phillip H. Hwang & Justin A. Cramer & Brigid C. Dwyer & Honglin Hao & , 2022. "Multimodal deep learning for Alzheimer’s disease dementia assessment," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    7. Xiuhua Yin & Hong Zhou & Mengling Zhang & Juan Su & Xiao Wang & Sijie Li & Zaixing Yang & Zhenhui Kang & Ruhong Zhou, 2023. "C3N nanodots inhibits Aβ peptides aggregation pathogenic path in Alzheimer’s disease," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    8. Li, Huixia & Zhao, Hongyong, 2022. "Mathematical model of Alzheimer’s disease with prion proteins interactions and treatment," Applied Mathematics and Computation, Elsevier, vol. 433(C).
    9. Ricarda Törner & Tatsiana Kupreichyk & Lothar Gremer & Elisa Colas Debled & Daphna Fenel & Sarah Schemmert & Pierre Gans & Dieter Willbold & Guy Schoehn & Wolfgang Hoyer & Jerome Boisbouvier, 2022. "Structural basis for the inhibition of IAPP fibril formation by the co-chaperonin prefoldin," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    10. V. S. Manu & Cristina Olivieri & Gianluigi Veglia, 2023. "AI-designed NMR spectroscopy RF pulses for fast acquisition at high and ultra-high magnetic fields," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    11. Jiyeon Lee & Haeryung Lee & Hyein Lee & Miram Shin & Min-Gi Shin & Jinsoo Seo & Eun Jeong Lee & Sun Ah Park & Soochul Park, 2023. "ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells," Nature Communications, Nature, vol. 14(1), pages 1-20, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-41986-0. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.